|
[ 0.00, 0.19 ) |
0.00 mg/100 ml
|
Sunkist Lot 3 |
Ho P.C., et al (2000) Content of CYP3A4 inhibitors, naringin, .... Pharmaceutica Acta Helvetiae 74:379-385 PubMed (10812937) |
0.00 mg/100 ml
|
Sunkist Lot 2 |
Ho P.C., et al (2000) Content of CYP3A4 inhibitors, naringin, .... Pharmaceutica Acta Helvetiae 74:379-385 PubMed (10812937) |
0.00 mg/100 ml
|
Dole 1 |
Ho P.C., et al (2000) Content of CYP3A4 inhibitors, naringin, .... Pharmaceutica Acta Helvetiae 74:379-385 PubMed (10812937) |
0.00 mg/100 ml
|
Rio Red Lot 2 |
Ho P.C., et al (2000) Content of CYP3A4 inhibitors, naringin, .... Pharmaceutica Acta Helvetiae 74:379-385 PubMed (10812937) |
0.05 mg/100 ml
|
Rio Red Lot 1 |
Ho P.C., et al (2000) Content of CYP3A4 inhibitors, naringin, .... Pharmaceutica Acta Helvetiae 74:379-385 PubMed (10812937) |
0.14 mg/100 ml
|
New Zealand Lot 1 |
Ho P.C., et al (2000) Content of CYP3A4 inhibitors, naringin, .... Pharmaceutica Acta Helvetiae 74:379-385 PubMed (10812937) |
|
[ 0.19, 0.37 ) |
0.32 mg/100 ml
|
New Zealand Lot 6 |
Ho P.C., et al (2000) Content of CYP3A4 inhibitors, naringin, .... Pharmaceutica Acta Helvetiae 74:379-385 PubMed (10812937) |
|
[ 0.37, 0.56 ) |
0.54 mg/100 ml
|
New Zealand Lot 2 |
Ho P.C., et al (2000) Content of CYP3A4 inhibitors, naringin, .... Pharmaceutica Acta Helvetiae 74:379-385 PubMed (10812937) |
|
[ 0.56, 0.75 ) |
0.62 mg/100 ml
|
New Zealand Lot 5 |
Ho P.C., et al (2000) Content of CYP3A4 inhibitors, naringin, .... Pharmaceutica Acta Helvetiae 74:379-385 PubMed (10812937) |
|
[ 1.68, 1.88 ) |
1.87 mg/100 ml
|
New Zealand Lot 4 |
Ho P.C., et al (2000) Content of CYP3A4 inhibitors, naringin, .... Pharmaceutica Acta Helvetiae 74:379-385 PubMed (10812937) |